A detailed history of Northstar Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Northstar Asset Management LLC holds 2,140 shares of ABBV stock, worth $387,639. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,140
Previous 2,140 -0.0%
Holding current value
$387,639
Previous $367,000 14.99%
% of portfolio
0.1%
Previous 0.09%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$154.79 - $180.76 $36,375 - $42,478
-235 Reduced 9.89%
2,140 $367,000
Q3 2023

Oct 25, 2023

BUY
$133.59 - $154.65 $26,718 - $30,930
200 Added 9.2%
2,375 $354,000
Q2 2023

Jul 28, 2023

BUY
$132.51 - $164.9 $1,325 - $1,649
10 Added 0.46%
2,175 $293,000
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $2,169 - $2,498
15 Added 0.7%
2,165 $345,000
Q2 2021

Aug 11, 2021

SELL
$105.21 - $117.21 $225,780 - $251,532
-2,146 Closed
0 $0
Q1 2021

Apr 21, 2021

SELL
$102.3 - $112.62 $26,086 - $28,718
-255 Reduced 10.62%
2,146 $232,000
Q4 2020

Jan 21, 2021

BUY
$80.49 - $108.67 $193,256 - $260,916
2,401 New
2,401 $257,000
Q3 2020

Oct 19, 2020

SELL
$85.91 - $100.83 $204,122 - $239,572
-2,376 Closed
0 $0
Q2 2020

Aug 03, 2020

BUY
$73.37 - $98.18 $174,327 - $233,275
2,376 New
2,376 $233,000
Q1 2020

Apr 20, 2020

SELL
$64.5 - $97.79 $169,119 - $256,405
-2,622 Closed
0 $0
Q4 2019

Jan 16, 2020

BUY
$72.13 - $90.25 $189,124 - $236,635
2,622 New
2,622 $232,000
Q2 2019

Jul 16, 2019

SELL
$65.7 - $83.98 $172,659 - $220,699
-2,628 Closed
0 $0
Q1 2019

May 01, 2019

SELL
$77.14 - $90.79 $7,714 - $9,079
-100 Reduced 3.67%
2,628 $212,000
Q3 2018

Nov 02, 2018

BUY
$88.91 - $98.84 $2,667 - $2,965
30 Added 1.11%
2,728 $258,000
Q2 2018

Aug 22, 2018

BUY
$89.78 - $106.23 $6,284 - $7,436
70 Added 2.66%
2,698 $250,000
Q3 2017

Oct 25, 2017

BUY
$69.85 - $89.22 $183,565 - $234,470
2,628
2,628 $234,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northstar Asset Management LLC Portfolio

Follow Northstar Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northstar Asset Management LLC with notifications on news.